AbbVie Strikes Deal to Acquire Allergan for About $63 Billion

AbbVie Strikes Deal to Acquire Allergan for About $63 Billion - WSJ

AbbVie Strikes Deal to Acquire Allergan for About $63 Billion · Drugmakers agree to one of the biggest mergers in the health sector this year.

Three factors that drove the transformational integration of AbbVie ...

That day, AbbVie officially closed its $63-billion acquisition of Allergan to create a larger, stronger and more diversified global ...

AbbVie to Acquire Allergan in Transformative Move for Both ...

The AbbVie Board and the Independent Allergan Directors announced today that they have reached agreement on the terms of a recommended ...

Abbvie to buy Allergan in $63bn deal - Financier Worldwide

Drug manufacturer Abbvie Inc is to acquire Irish rival Allergan Plc for around $63bn in a cash and stock transaction.

AbbVie to buy Allergan in $63B cash and stock deal

AbbVie plans to acquire Allergan in a cash and stock deal valued at $63 billion, one of the biggest mergers in the healthcare industry this year ...

AbbVie Strikes Deal to Acquire Allergan for About $63 Billion

AbbVie has reached a deal to buy Allergan for about $63 billion, as two big drugmakers bet a combination will deliver new sources of growth ...

AbbVie Strikes Deal With the FTC to Move Its Allergan Acquisition ...

In June, AbbVie (NYSE: ABBV) made a bid to purchase Allergan (NYSE: AGN) in a cash and stock transaction valued at $63 billion. AbbVie likely decided to ...

AbbVie Strikes Deal With the FTC to Move Its Allergan Acquisition ...

In June, AbbVie (ABBV -0.99%) made a bid to purchase Allergan (AGN) in a cash and stock transaction valued at $63 billion.

Drugmakers AbbVie and Allergan strike $63M merger deal

AbbVie Inc. has agreed to pay $63 billion for rival drugmaker Allergan Plc, the latest huge merger in a pharmaceutical sector rapidly being reshaped by deals.

AbbVie strikes $63-billion deal for merger with botox-maker Allergan

AbbVie Inc. agreed to pay $63 billion for rival drugmaker Allergan Plc, the latest merger in an industry where some of the biggest companies have been willing ...

AbbVie Strikes $63 Billion Deal For Botox-Maker Allergan - FA Mag

AbbVie Inc. has agreed to pay $63 billion for rival drugmaker Allergan Plc, the latest huge merger in a pharmaceutical sector rapidly being reshaped by ...

Illinois-based drugmaker AbbVie to buy rival Allergan for $63 billion

North Chicago-based drugmaker AbbVie is buying Botox-maker Allergan for $63 billion in cash and stock — a deal designed to reduce AbbVie's ...

AbbVie to Purchase Botox Maker Allergan in $63 Billion Deal

AbbVie Inc. agreed to buy Allergan Plc in a $63 billion deal that unites the rival drug makers in a bid for growth.

AbbVie to acquire Allergan for $63 billion - C&EN

Staring down a future without the lucrative arthritis treatment Humira, AbbVie has responded with a deal to acquire Allergan for $63 billion.

Facing The Upcoming Loss Of Blockbuster Drug's Patent Protections ...

Facing The Upcoming Loss Of Blockbuster Drug's Patent Protections, AbbVie Buys Allergan In Mega $63B Deal. “This is the age of blockbusters,” ...

AbbVie Wins U.S. Antitrust Nod for Botox Maker Allergan - Bloomberg

... approval for its acquisition of Botox maker Allergan Plc, clearing the last hurdle from competition regulators to the $63 billion deal.

AbbVie Strikes $63 Billion Deal For Botox-Maker Allergan - FA Mag

AbbVie Inc. has agreed to pay $63 billion for rival drugmaker Allergan Plc, the latest huge merger in a pharmaceutical sector rapidly being ...

AbbVie buying Allergan in $63B deal for its post-Humira future

AbbVie on Tuesday announced it will acquire Allergan in a $63 billion deal, delivering a forceful answer to growing shareholder questions ...

Helen Lee, PharmD, MBA, CDE on LinkedIn: AbbVie Strikes Deal to ...

Abbie and Allergan are merging for further growth. This acquisition is one of the largest-ever industry takeovers. AbbVie is about to lose patent ...

AbbVie to buy Allergan in $63 billion drug deal | CNN Business

AbbVie announced it will buy Allergan for $63 billion, combining the companies behind Humira and Botox and creating yet another pharmaceutical behemoth.